NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

LightStrike™ Germ-Zapping Robot™

The Xenex LightStrike™ Germ-Zapping Robot™ is the only UV disinfection technology proven, in multiple peer-reviewed studies, to help hospitals reduce infection rates. Xenex pulsed xenon UV disinfection robots have helped health care facilities decrease their MRSA, C.diff and surgical site infection rates by more than 50, 70 and 100 percent respectively (according to peer-reviewed literature). Designed for speed, effectiveness and ease of use, the Xenex robot destroys viruses, bacteria and bacterial spores in four-minute disinfection cycles. Unlike other UV devices that use bulbs containing toxic mercury to produce low-intensity UV light, Xenex is the only technology that uses high-intensity Full Spectrum™ pulsed xenon UV light.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X